// App-Quantinova.ai

: Mepolizumab reduces disease symptoms for Patients with Chronic Rhinosinusitis with Nasal Polyps: Data from the SYNAPSE study

Researchers

Presenter

  • Maggie Tabberer

Principal Investigators

  • Andrew Trigg

  • William Busse

  • Valerie Lund

  • Jason Lee

  • Claus Bachert

  • Brent Senior

  • Kathleen Buchheit

  • Zuzana Diamant

  • Ana Sousa

  • Steven Smith

  • Bhabita Mayer

  • Steven Yancey

  • Robert Chan

Medical Centers

  • GSK, Stockley Park, Uxbridge, Middlesex, UK

  • Adelphi Values Ltd, Manchester, UK

  • University of Wisconsin, Madison, Wisconsin, United States

  • University College London, London, UK

  • Toronto Allergy and Asthma Clinic, Toronto, ON, Canada

  • Ghent University and University Hospital, Ghent, Belgium

  • University of North Carolina, Chapel Hill, NC

  • Brigham & Women's Hospital, Boston, MA

  • Lund University Hospital and Lund University, Lund, Sweden

  • GSK, Stockley Park, Uxbridge, UK

  • GSK, Research Triangle Park, NC, USA

  • GSK, Research Triangle Park, NC, USA

  • GSK, Stevenage

Locations

  • United Kingdom

  • United States

  • Canada

  • Belgium

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved